• @kinsnik
    link
    299 months ago

    i wish that they would also reschedule lsd and psilocybin to schedule III, but at least some progress is better than no progress

    • @ChonkyOwlbear
      link
      169 months ago

      Seriously. There have to be more people who die from ketamine than LSD every year. It all seems so arbitrary.

      • @jeansburger
        link
        49 months ago

        It is arbitrary. While what classification a substance is may have some grounding in research, it’s mostly up to what interest group has either lobbied to get something under or whatever group law enforcement wants to be able to get easy charges for. Cannabis was Sched I because it made it easy for law enforcement to get big sentences for minorities and the counter culture participants of the day. Same thing with LSD and psilocybin.

        All the DEA scheduling is just pick and choose your charge for whatever ideological ax they want to grind. Hence why things don’t line up with reality

    • @[email protected]
      link
      fedilink
      89 months ago

      And MDMA? It shows a lot of promise in therapeutic use. Schedule 1 is for substances with “no currently accepted medical treatment use”.

      • @kinsnik
        link
        29 months ago

        Yeah, MDMA also doesn’t belong in schedule I, although it is definitely more risky than lsd and mushrooms

          • @kinsnik
            link
            29 months ago

            Overdose of MDMA can cause seratonin syndrome, which can be fatal; and long term use might be linked to depression and anxiety (again, by the way it interacts with seratonin)

            It definitely should be rescheduled too, since it is not dangerous enough and definitely has potential for medical use (couple therapy was it’s original use)